Selecta Biosciences Reports Q2 Revenue Of $19.7 Mln

T-Reuters2021-08-12

Selecta Biosciences Inc:Selecta Biosciences Reports Second Quarter 2021 Financial Results And Provides Business Update.Q2 Revenue $19.7 Million.Q2 Revenue Estimate $7.1 Million -- Refinitiv Ibes Data.Selecta Biosciences - Cash, Cash Equivalents, Marketable Securities As Of June 30, 2021 Expected To Provide Runway Into Q3 Of 2023.Qtrly Basic Net Income Per Share Of $0.04.Qtrly Diluted Net Income Per Share $0.00.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
4